Mumbai: Emerging regenerative medicine approaches may offer new hope for patients suffering from lipodermatosclerosis, a chronic inflammatory skin condition linked to venous insufficiency, according to a clinical case report.
Lipodermatosclerosis is characterized by pain, swelling, skin discoloration, hardening of tissues, and, in severe cases, ulceration of the lower legs. The condition is often associated with poor blood circulation, obesity, and chronic venous disease.
Traditional treatment options include compression therapy, physiotherapy, weight management, medication, and, in some cases, surgery. However, researchers and clinicians are increasingly exploring cell-based therapies as a potential alternative for difficult-to-treat cases.
A reported case involved a 78-year-old woman diagnosed with lipodermatosclerosis and vasculitis who had experienced persistent pain, swelling, skin lesions, and itching for nearly two years. She underwent three sessions of cell-based therapy using regenerative cells and growth factors derived from her own body.
According to the case report, noticeable improvement was observed within days of treatment. Over a six-month follow-up period, the patient reportedly experienced significant reduction in pain and swelling, improved mobility, healing of skin lesions, and decreased inflammation.
